Who are Evofem Biosciences, Inc.'s main suppliers?

Evofem Biosciences, Inc. (EVFM) key suppliers include: CLOVIS-DAVIS-PHARMACEUTICALS-LLC, WINDTREE-THERAPEUTICS-INC, Windtree Therapeutics, Inc., HUBCZ, Johnson & Johnson and 5 more. View the full supplier network at chainsifter.com/chain/EVFM.

Who are Evofem Biosciences, Inc.'s major customers?

Evofem Biosciences, Inc. (EVFM) key customers include: WINDTREE THERAPEUTICS INC C/WTS, PHARMA-1, HUBCZ, Johnson & Johnson, Johnson & Johnson and 7 more. View the full customer network at chainsifter.com/chain/EVFM.

What sector is Evofem Biosciences, Inc. in?

Evofem Biosciences, Inc. (EVFM) operates in the general sector. ChainSifter tracks its verified supply chain relationships including suppliers, customers, and strategic partners.

Evofem Biosciences, Inc. Suppliers, Customers & Supply Chain (EVFM)

10Suppliers

12Customers

3Debt Items

20Related Chains

Source-Backed Evidence Depth

Evofem Biosciences, Inc. (EVFM) is shown with relationship data already present in ChainSifter's database. Counts below come from stored supply-chain records and filing/source URLs where available; missing source URLs are not filled in or estimated.

25Total relationships

4Distinct source URLs

8High confidence

0.776Average confidence

2026-10-28Latest database update

ChainSifter does not infer unreported suppliers, customers, ownership, acquisitions, debt exposure, revenue dependency, or future supply-chain events on this public page.

Evofem Biosciences, Inc. Suppliers

Ticker	Name	Confidence	Evidence
CLOVIS-DAVIS-PHARMACEUTICALS-LLC	CLOVIS-DAVIS-PHARMACEUTICALS-LLC	92%	Under the distributorship agreement, Clovis Davis will lead the distribution, promotion, marketing, and sales of SOLOSEC within the Territory.
WINDTREE-THERAPEUTICS-INC	WINDTREE-THERAPEUTICS-INC	92%	On March 20, 2025, Windtree Therapeutics, Inc. (Windtree) and the Company entered into a License and Supply Agreement, as amended on March 28, 2025 (collectively, the Windtree License and Supply Agre…
WINT	Windtree Therapeutics, Inc.	90%	Reciprocal relationship from WINT graph: we will act as the supplier to Evofem of its Phexxi® product outside of the United States
HUBCZ	HUBCZ	72%	Reciprocal relationship from HUBCZ graph: s cyber risk assessment, risk mitigation and cyber incident response services to customers worldwide. Comsec customers are large enterprises, militaries and …
JNJ	Johnson & Johnson	72%	umber of sales employees; this negatively impacted our ability to maintain our sales and marketing capabilities. Any failure or future delay in the timely development of our internal commercializatio…
JNJ	Johnson & Johnson	72%	Reciprocal relationship from JNJ graph: Reciprocal relationship from EVFM graph: umber of sales employees; this negatively impacted our ability to maintain our sales and marketing capabilities. Any f…
MRK	Merck & Co., Inc.	72%	umber of sales employees; this negatively impacted our ability to maintain our sales and marketing capabilities. Any failure or future delay in the timely development of our internal commercializatio…
MRK	Merck & Co., Inc.	72%	Reciprocal relationship from MRK graph: Reciprocal relationship from EVFM graph: umber of sales employees; this negatively impacted our ability to maintain our sales and marketing capabilities. Any f…
ORANY	ORANY	72%	n such a competitor or third party would then be able to introduce a competitive generic product onto the market once any available regulatory exclusivity has expired. The FDA has broad discretion in…
ORANY	ORANY	72%	Reciprocal relationship from ORANY graph: Reciprocal relationship from EVFM graph: n such a competitor or third party would then be able to introduce a competitive generic product onto the market onc…

Evofem Biosciences, Inc. Customers

Ticker	Name	Confidence	Evidence
WINTW	WINDTREE THERAPEUTICS INC C/WTS	92%	Reciprocal relationship from WINTW graph: Reciprocal relationship from EVFM graph: Reciprocal relationship from WINTW graph: Pursuant to the L&S Agreement, we will act as the supplier to Evofem of it…
PHARMA-1	PHARMA-1	90%	and, in the UAE, its licensee, Pharma 1.
HUBCZ	HUBCZ	72%	Reciprocal relationship from HUBCZ graph: s cyber risk assessment, risk mitigation and cyber incident response services to customers worldwide. Comsec customers are large enterprises, militaries and …
JNJ	Johnson & Johnson	72%	Reciprocal relationship from JNJ graph: Reciprocal relationship from EVFM graph: umber of sales employees; this negatively impacted our ability to maintain our sales and marketing capabilities. Any f…
JNJ	Johnson & Johnson	72%	umber of sales employees; this negatively impacted our ability to maintain our sales and marketing capabilities. Any failure or future delay in the timely development of our internal commercializatio…
MRK	Merck & Co., Inc.	72%	Reciprocal relationship from MRK graph: Reciprocal relationship from EVFM graph: umber of sales employees; this negatively impacted our ability to maintain our sales and marketing capabilities. Any f…
MRK	Merck & Co., Inc.	72%	umber of sales employees; this negatively impacted our ability to maintain our sales and marketing capabilities. Any failure or future delay in the timely development of our internal commercializatio…
ORANY	ORANY	72%	Reciprocal relationship from ORANY graph: Reciprocal relationship from EVFM graph: n such a competitor or third party would then be able to introduce a competitive generic product onto the market onc…
ORANY	ORANY	72%	n such a competitor or third party would then be able to introduce a competitive generic product onto the market once any available regulatory exclusivity has expired. The FDA has broad discretion in…
WINT	Windtree Therapeutics, Inc.	72%	ial in each of the three months ended March 31, 2026 and 2025. As of March 31, 2026, $ 0.1 million and $ 1.1 million for the future payments that could become due related to the SOLOSEC acquisition, …
WINT	Windtree Therapeutics, Inc.	72%	Reciprocal relationship from WINT graph: Reciprocal relationship from EVFM graph: ial in each of the three months ended March 31, 2026 and 2025. As of March 31, 2026, $ 0.1 million and $ 1.1 million …
FUTURE-PAK-LLC	FUTURE-PAK-LLC	62%	organizations) are able to purchase products at a price discounted below WAC. The difference between the government or covered entity purchase price and the wholesale distributor purchase price of WA…

Evofem Biosciences, Inc. Debt Obligations

Instrument	Description	Confidence	Evidence
EVFM-DEBT	Debt stack $4.0M	90%	Market cache reports total debt of $4.0M.
EVFM-DEBT-9389	Warrants outstanding: 263062097	90%	xbrl warrant detail from xbrl 2026-03-31.
EVFM-DEBT-9390	Xbrl Convertible	90%	xbrl convertible detail from xbrl 2024-12-31.

Evofem Biosciences, Inc. Acquisitions

No acquisitions on recordNo completed or pending acquisitions found in our database for Evofem Biosciences, Inc..

Evofem Biosciences, Inc. Ownership

No ownership data on recordNo major institutional ownership relationships found in our database for Evofem Biosciences, Inc..

Evofem Biosciences, Inc. Extended Supply Chain Network

Ticker	Name	Chain Index	Hops	Relationship Types
HUBCZ	Hub Cyber Security Ltd.	100.00	1	['customer', 'supplier']
MRK	Merck & Co., Inc.	100.00	1	['customer', 'supplier']
JNJ	Johnson & Johnson	100.00	1	['customer', 'supplier']
ORANY	ORANGE	100.00	1	['customer', 'supplier']
WINTW	WINDTREE THERAPEUTICS INC C/WTS	100.00	1	['customer']
WINT	Windtree Therapeutics, Inc.	100.00	1	['customer', 'supplier']
ASBPW	Aspire Biopharma Holdings, Inc.	50.00	2
BLTE	Belite Bio, Inc	50.00	2
BCDRF	Banco Santander, S.A.	50.00	2
BFRIW	Biofrontera Inc.	50.00	2
AMZE	Amaze Holdings, Inc.	50.00	2
CPRX	Catalyst Pharmaceuticals, Inc.	50.00	2
ARQQW	Arqit Quantum Inc.	50.00	2
AYTU	Aytu BioPharma, Inc.	50.00	2
AMXOF	AMERICA MOVIL SAB DE CV/	50.00	2
BLNK	Blink Charging Co.	50.00	2
D	Dominion Energy, Inc.	50.00	2
CMCM	Cheetah Mobile Inc.	50.00	2
CINGW	Cingulate Inc.	50.00	2
BLLN	BillionToOne, Inc.	50.00	2

Evofem Biosciences, Inc. Supply Chain